In the vast majority of cases of Parkinson’s disease, or “shaking palsy,” physicians cannot be sure what originally caused the nerve damage that results in the patient’s tremor, muscle rigidity, ...
Involuntary movements (dyskinesia) develop in the course of Parkinson's disease (PD) and can be treatment-limiting. Two processes seem to be important: the 'priming' of motor systems for the ...
Philadelphia (April 1, 2022) – Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson’s disease. Preclinical ...
The U.S. Food and Drug Administration has given approval for the drug Stalevo-a cocktail of levodopa (L-dopa), carbidopa, and entacapone-to be marketed in the United States for the treatment of ...
In a scientific first, researchers have turned plastic waste into a mainstay treatment for Parkinson’s disease (PD). In a proof-of-concept study, researchers used engineered bacteria to convert ...
Researchers at the University of Edinburgh are working on engineering bacteria to convert chemicals derived from waste plastic bottles into L-DOPA, a key drug used to treat Parkinson’s disease. The ...
A drug used to treat Parkinson's disease could also help people with phobias or post-traumatic stress disorder (PTSD). Scientists of the Translational Neurosciences (FTN) Research Center at Johannes ...
A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD). Led by 2014 BBRF ...
From the Medical Research Center, Brookhaven National Laboratory, Upton, L.I., and the Faculty of Medicine, Catholic University, Santiago, Chile (address reprint requests to Dr. Cotzias at the Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results